Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.

During the COVID-19 pandemic, the Ad5-nCoV vaccine was applied to the Mexican population before the WHO approved it. In a transversal study, we compare the CanSino vaccine efficacy and a natural SARS-CoV-2 infection in eliciting neutralizing antibodies against the SARS-CoV-2 Delta variant in Guadalajara, Mexico. Participants between 30-60 years were included in the study and classified into three groups: 1) Natural immunity (unvaccinated), 2) Vaccine-induced immunity (vaccinated individuals without a COVID-19 history), and 3) Natural immunity + vaccine-induced immunity. These groups were matched by age and gender. We assessed the ability of individuals' serum to neutralize the Delta variant and compared the results of the different groups using a neutralization test followed by plaque-forming units. Results showed that 39% of individuals' serum with a history of COVID-19 (natural immunity, Group 1) could not neutralize the Delta variant, compared to 33% in vaccinated individuals without COVID-19 (vaccine immunity, Group 2). In contrast, only 7% of vaccinated individuals with a history of COVID-19 (natural + vaccine immunities) could not neutralize the Delta variant. We concluded that the effectiveness of the Ad5-nCoV vaccine to induce neutralizing antibodies against the Delta variant is comparable to that of natural infection (61% vs. 67%). However, in individuals with both forms of immunity (Group 3), it increased to 93%. Based on these results, despite the Ad5-nCoV vaccine originally being designed as a single-dose regimen, it could be recommended that even those who have recovered from COVID-19 should consider vaccination to boost their immunity against this variant.

Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.

Few studies analyze the role of B-cell subpopulations in rheumatoid arthritis (RA) pathophysiology. Therefore, this study aimed to analyze the differences in B-cell subpopulations and B-cell activation according to disease activity, RA subtype, and absence of disease-modifying antirheumatic drugs (DMARDs) therapy. These subgroups were compared with control subjects (CS). One hundred and thirty-nine subjects were included, of which 114 were RA patients, and 25 were controls. Patients were divided into 99 with seropositive RA, 6 with seronegative RA, and 9 without DMARDs. The patients with seropositive RA were subclassified based on the DAS28 index. A seven-color multicolor flow cytometry panel was used to identify B-cell immunophenotypes and cell activation markers. There were no changes in total B-cell frequencies between RA patients and controls. However, a lower frequency of memory B cells and pre-plasmablasts was observed in seropositive RA compared to controls (P < 0.0001; P = 0.0043, respectively). In contrast, a higher frequency of mature B cells was observed in RA than in controls (P = 0.0002). Among patients with RA, those with moderate activity had a higher percentage of B cells (P = 0.0021). The CD69+ marker was increased (P < 0.0001) in RA compared to controls, while the CD40+ frequency was decreased in patients (P < 0.0001). Transitional, naïve, and double-negative B-cell subpopulations were higher in seronegative RA than in seropositive (P < 0.01). In conclusion, in seropositive and seronegative RA patients, there are alterations in B-cell activation and B-cell subpopulations, independently of clinical activity and DMARDs therapy.

BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study.

This study aimed to analyze the dynamics, duration, and production of total and neutralizing antibodies induced by the BNT162b2 vaccine and the possible effect of gender and prior SARS-CoV-2 infection on the generation of these antibodies. Total antibodies were quantified via chemiluminescent microparticle immunoassay (CMIA), and neutralizing antibodies were quantified using the cPass SARS-CoV-2 kit. Individuals with a history of COVID-19 produced twice as many antibodies than vaccinated individuals without prior SARS-CoV-2 infection, with an exponential increase observed in just six days. In those without a COVID-19 history, similar antibody production was reached 45 days after vaccination. Although total antibodies decline considerably in the first two months, the neutralizing antibodies and their inhibitory capacity (>96%) persist up to 6 months after the first dose. There was a tendency for higher total antibodies in women than men, but not at the inhibition capacity level. We suggest that the decline in total antibodies should not be considered as an indicator of loss of protective immunity because most antibodies decay two months after the second dose, but neutralizing antibodies remain constant for at least six months. Therefore, these latter antibodies could be better indicators for estimating the time-dependent vaccine efficacy.

Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk.

Suicide is one of the leading causes of death worldwide. According to the World Health Organization (WHO), every year, more than 700 thousand people die from this cause. Therefore, suicide is a public health issue. The complex interaction between different factors causes suicide; however, depression is one of the most frequent factors in people who have attempted suicide. Several studies have reported that vitamin D deficiency may be a relevant risk factor for depression, and vitamin D supplementation has shown promising effects in the adjunctive treatment of this mood disorder. Among the beneficial mechanisms of vitamin D, it has been proposed that it may enhance serotonin synthesis and modulate proinflammatory cytokines since low serotonin levels and systemic inflammation have been associated with depression and suicide. The present narrative review shows the potential pathogenic role of vitamin D deficiency in depression and suicide and the potential benefits of vitamin D supplementation to reduce their risk.

Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies.

Neutralizing antibodies (NAbs) can be indicators of collective immunity, vaccine efficacy, and the longevity of the humoral response. This study aimed to compare reactogenicity and NAbs generated by three different COVID-19 vaccine platforms in individuals with and without prior COVID-19. 336 individuals vaccinated (112 with CoronaVac [inactivated virus], 112 with BNT162b2 [messenger RNA], and 112 with Ad5-nCoV [non-replicating viral vector]) were included. NAbs were quantified with the cPass SARS-CoV-2 kit. Individuals immunized with the Ad5-nCoV showed higher reactogenicity than those immunized with the other vaccines (p < 0.001). The BTN162b2 vaccine-induced NAbs with higher inhibition capacity than the other platforms in the first dose. In individuals without prior COVID-19, the Ad5-nCoV vaccine generated lower NAbs against SARS-CoV-2 than those induced by two doses of the BTN162b2 (Ad5-nCoV 72.10 [55.6-93.4] vs. BTN162b2 98.41 [98.16-98.56], p < 0.0001). One individual did not generate NAbs (0.89%) after a complete immunization with CoronaVac; in BTN162b2, all generated these antibodies, and in the Ad5-nCoV group, four individuals (3.57%) did not generate NAbs. Comorbidities, gender, age, and reactogenicity did not significantly influence the generation of NAbs (p > 0.05); however, a history of COVID-19 before vaccination was associated with antibodies with greater neutralizing capacity after the first dose (p < 0.01). In conclusion, the mRNA vaccine (BTN162b2) had a remarkable better ability to produce NAbs and lower reactogenicity than the other platforms, whereas the Ad5-nCov vaccine induced the lowest NAbs response in individuals without a history of COVID-19; therefore, we suggest that a booster could benefit these individuals.

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study.

Purpose: Understanding the humoral immune response dynamics carried out by B cells in COVID-19 vaccination is little explored; therefore, we analyze the changes induced in the different cellular subpopulations of B cells after vaccination with BNT162b2 (Pfizer-BioNTech). Methods: This prospective cohort study evaluated thirty-nine immunized health workers (22 with prior COVID-19 and 17 without prior COVID-19) and ten subjects not vaccinated against SARS-CoV-2 (control group). B cell subpopulations (transitional, mature, naïve, memory, plasmablasts, early plasmablast, and double-negative B cells) and neutralizing antibody levels were analyzed and quantified by flow cytometry and ELISA, respectively. Results: The dynamics of the B cells subpopulations after vaccination showed the following pattern: the percentage of transitional B cells was higher in the prior COVID-19 group (p < 0.05), whereas virgin B cells were more prevalent in the group without prior COVID-19 (p < 0.05), mature B cells predominated in both vaccinated groups (p < 0.01), and memory B cells, plasmablasts, early plasmablasts, and double-negative B cells were higher in the not vaccinated group (p < 0.05). Conclusion: BNT162b2 vaccine induces changes in B cell subpopulations, especially generating plasma cells and producing neutralizing antibodies against SARS-CoV-2. However, the previous infection with SARS-CoV-2 does not significantly alter the dynamics of these subpopulations but induces more rapid and optimal antibody production.

Development and Validation of a Virtual Reality Simulator for Robot-Assisted Minimally Invasive Liver Surgery Training.

The value of kinematic data for skill assessment is being investigated. This is the first virtual reality simulator developed for liver surgery. This simulator was coded in C++ using PhysX and FleX with a novel cutting algorithm and used a patient data-derived model and two instruments functioning as ultrasonic shears. The simulator was evaluated by nine expert surgeons and nine surgical novices. Each participant performed a simulated metastasectomy after training. Kinematic data were collected for the instrument position. Each participant completed a survey. The expert participants had a mean age of 47 years and 9/9 were certified in surgery. Novices had a mean age of 30 years and 0/9 were certified surgeons. The mean path length (novice 0.76 ± 0.20 m vs. expert 0.46 ± 0.16 m, p = 0.008), movements (138 ± 45 vs. 84 ± 32, p = 0.043) and time (174 ± 44 s vs. 102 ± 42 s, p = 0.004) were significantly different for the two participant groups. There were no significant differences in activating the instrument (107 ± 25 vs. 109 ± 53). Participants considered the simulator realistic (6.5/7) (face validity), appropriate for education (5/7) (content validity) with an effective interface (6/7), consistent motion (5/7) and realistic soft tissue behavior (5/7). This study showed that the simulator differentiates between experts and novices. Simulation may be an effective way to obtain kinematic data.

Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study.

Several studies have reported the benefits and safety of heterologous vaccination among different approved vaccines; however, there are no specific reports on the effects of vaccination with the Ad5-nCoV and other vaccines of the same or different technologies. In the present study, we evaluated the neutralizing antibodies percentage against SARS-CoV-2 in Mexican patients immunized with the Ad5-nCoV vaccine six months after its application. Moreover, the effect of the heterologous vaccination with the Ad5-nCoV vaccine and a booster dose of ChAdOx1-S-Nov-19, Ad26.COV2.S, BNT162b2, or mRNA-127 were determined. Our results suggest that a heterologous regimen of one dose with Ad5-nCoV vaccine followed by a booster dose of a different vaccine is safe and induces a stronger humoral immune response.

Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.

This is the first study outside of clinical trials (phase I-III) evaluating the ability of the Ad5-nCoV vaccine to generate neutralizing antibodies and the factors associated with optimal or suboptimal response. In a longitudinal assay, 346 people (117 with prior COVID-19 and 229 without prior COVID-19) vaccinated with Ad5-nCoV were recruited. The percentage of neutralizing antibodies against SARS-CoV-2 (Surrogate Virus Neutralization Test) and antibodies against Ad5 (ADV-Ad5 IgG ELISA) were quantified pre and post-vaccination effects. The Ad5-nCoV vaccine induces higher neutralizing antibodies percentage in individuals with prior COVID-19 than those without prior COVID-19 (median [IQR]: 98% [97-98.1] vs. 72% [54-90], respectively; p < 0.0001). Furthermore, a natural infection (before vaccination) induces more neutralizing antibodies percentage than immunized individuals without prior COVID-19 (p < 0.01). No patient had vaccine-severe adverse effects. The age, antidepressant, and immunosuppressive treatments, reactogenicity, and history of COVID-19 are associated with impaired antibody production. The anti-Ad5 antibodies increased after 21 days of post-vaccination in all groups (p < 0.01). We recommend the application of a booster dose of Ad5-nCoV, especially for those individuals without previous COVID-19 infection. Finally, the induction of anti-Ad5 antibodies after vaccination should be considered if a booster with the same vaccine is planned.

The effects of different levels of realism on the training of CNNs with only synthetic images for the semantic segmentation of robotic instruments in a head phantom.

PURPOSE: The manual generation of training data for the semantic segmentation of medical images using deep neural networks is a time-consuming and error-prone task. In this paper, we investigate the effect of different levels of realism on the training of deep neural networks for semantic segmentation of robotic instruments. An interactive virtual-reality environment was developed to generate synthetic images for robot-aided endoscopic surgery. In contrast with earlier works, we use physically based rendering for increased realism. METHODS: Using a virtual reality simulator that replicates our robotic setup, three synthetic image databases with an increasing level of realism were generated: flat, basic, and realistic (using the physically-based rendering). Each of those databases was used to train 20 instances of a UNet-based semantic-segmentation deep-learning model. The networks trained with only synthetic images were evaluated on the segmentation of 160 endoscopic images of a phantom. The networks were compared using the Dwass-Steel-Critchlow-Fligner nonparametric test. RESULTS: Our results show that the levels of realism increased the mean intersection-over-union (mIoU) of the networks on endoscopic images of a phantom ([Formula: see text]). The median mIoU values were 0.235 for the flat dataset, 0.458 for the basic, and 0.729 for the realistic. All the networks trained with synthetic images outperformed naive classifiers. Moreover, in an ablation study, we show that the mIoU of physically based rendering is superior to texture mapping ([Formula: see text]) of the instrument (0.606), the background (0.685), and the background and instruments combined (0.672). CONCLUSIONS: Using physical-based rendering to generate synthetic images is an effective approach to improve the training of neural networks for the semantic segmentation of surgical instruments in endoscopic images. Our results show that this strategy can be an essential step in the broad applicability of deep neural networks in semantic segmentation tasks and help bridge the domain gap in machine learning.

Rapid method for the determination of citrate, phosphate and sulfite in seafood by capillary zone electrophoresis.

Since seafood is susceptible to decomposition, additives may be used to maintain its quality. However, some additives may be improperly used to disguise spoilage, thus resulting in food fraud. Market growth demands faster and more reliable quality control tools that incorporate the most common additives in a single analysis. This study developed a rapid analytical method for the determination of citrate, phosphate and sulfite in seafood by capillary zone electrophoresis with indirect UV-Vis detection. Electrophoretic separation was achieved in less than 3.5 min. The background electrolyte consisted of 20 mmol L-1 of benzenesulfonic acid and 45 mmol L-1 of aminocaproic acid. After validation, the method was applied for 24 seafood real samples. Citrate was found in five samples. Four samples presented higher phosphate and sulfite concentrations than those permitted by Brazilian legislation. Good analytical performance indicates that the method is a viable alternative for food control in routine analysis.

Automatic annotation of surgical activities using virtual reality environments.

PURPOSE: Annotation of surgical activities becomes increasingly important for many recent applications such as surgical workflow analysis, surgical situation awareness, and the design of the operating room of the future, especially to train machine learning methods in order to develop intelligent assistance. Currently, annotation is mostly performed by observers with medical background and is incredibly costly and time-consuming, creating a major bottleneck for the above-mentioned technologies. In this paper, we propose a way to eliminate, or at least limit, the human intervention in the annotation process. METHODS: Meaningful information about interaction between objects is inherently available in virtual reality environments. We propose a strategy to convert automatically this information into annotations in order to provide as output individual surgical process models. VALIDATION: We implemented our approach through a peg-transfer task simulator and compared it to manual annotations. To assess the impact of our contribution, we studied both intra- and inter-observer variability. RESULTS AND CONCLUSION: In average, manual annotations took more than 12 min for 1 min of video to achieve low-level physical activity annotation, whereas automatic annotation is achieved in less than a second for the same video period. We also demonstrated that manual annotation introduced mistakes as well as intra- and inter-observer variability that our method is able to suppress due to the high precision and reproducibility.

Virtual reality simulation of robotic transsphenoidal brain tumor resection: Evaluating dynamic motion scaling in a master-slave system.

BACKGROUND: Integrating simulators with robotic surgical procedures could assist in designing and testing of novel robotic control algorithms and further enhance patient-specific pre-operative planning and training for robotic surgeries. METHODS: A virtual reality simulator, developed to perform the transsphenoidal resection of pituitary gland tumours, tested the usability of robotic interfaces and control algorithms. It used position-based dynamics to allow soft-tissue deformation and resection with haptic feedback; dynamic motion scaling control was also incorporated into the simulator. RESULTS: Neurosurgeons and residents performed the surgery under constant and dynamic motion scaling conditions (CMS vs DMS). DMS increased dexterity and reduced the risk of damage to healthy brain tissue. Post-experimental questionnaires indicated that the system was well-evaluated by experts. CONCLUSION: The simulator was intuitively and realistically operated. It increased the safety and accuracy of the procedure without affecting intervention time. Future research can investigate incorporating this simulation into a real micro-surgical robotic system.

Small skin incision and fistula elevation for hemodialysis using the femoral vein.

BACKGROUND: Wound morbidity commonly accompanies transposition of the femoral vein when used for hemodialysis access, mainly because of the length of the skin incision. A short incision may reduce wound complications but may compromise the arteriovenous (AV) function because of the shorter length of femoral vein available for puncture. This report presents our experience with a modification of the original technique, in which a smaller skin incision and fistula elevation were used. METHODS: The clinical course of 25 AV fistulas in the thigh using the femoral vein was retrospectively analyzed. The original technique to create femoral AV access was used in 12 patients and the modified technique in 13. The procedures were performed between 2005 and 2007, and patients were monitored until January 31, 2011. RESULTS: Three fistulas failed in each group. Five patients in the original group had wound complications. No wound complications occurred in the modified group. The fistula was first used at an average of 10.45 weeks and 6.14 weeks, respectively. Patency was similar in both groups. CONCLUSIONS: It is possible to obtain a functional AV fistula in the thigh using the femoral vessels and limiting the extent of the incision. Long-term patency is reasonable, despite the use of a short femoral segment for puncture.

Mejoría del perfil de lípidos y la función endotelial con fenofibrato en pacientes con síndrome metabólico y nivel de C-LDL dentro del objetivo terapéutico / Improvement of the lipid profile and endothelial function with fenofibrate in patients with metabolic syndrome and C-LDL level within the therapeutic goal

Antecedentes: El síndrome metabólico (SM) por su elevada frecuencia y porque aumenta el riesgo de desarrollar diabetes y eventos cardiovasculares se ha convertido en un problema de salud pública en México. Uno de sus componentes es la dislipidemia aterogénica la cual está constituida por hipoalfalipoproteinemia, hipertrigliceridemia y C-LDL en niveles variables incluso normales, sin embargo las guías internacionales señalan al C-LDL como el objetivo primario del tratamiento, lo que ocasiona que en la práctica clínica con frecuencia se omita corregirlos niveles de TG y C-HDL lo que mantiene un riesgo residual en estos pacientes. No existe una recomendación oficial sobre el tratamiento de enfermos con SM, hipertrigliceridemia, hipoalfalipoproteinemia y C-LDL en meta ni estudios que exploren las condiciones vasculares de estos pacientes ni la respuesta al tratamiento con un fibrato. Objetivo: Determinar el efecto del fenofibrato sobre el perfil de lípidos y el estado vascular de pacientes con SM y la dislipidemia descrita .Método: Se incluyeron 12 pacientes en un estudio prospectivo, longitudinal, cruzado, doble ciego, controlado con placebo a base de 160 mg diarios de fenofibrato durante 8 semanas. Se evaluaron perfil de lípidos séricos, función endotelial mediante vasodilatación dependiente de flujo y espesor de la íntima-media carotídea de control y al finalizar el tratamiento. Resultados: El fenofibrato redujo significativamente los niveles de TG, incrementó los valores de C-HDL y mejoró la función endotelial en la mayor parte de los pacientes, esto se asoció significativamente con el descenso en los valores de TG (..) (AU)

Backgrounds: The metabolic syndrome (MS), due to its elevated frequency and because it increases the risk of developing diabetes and having cardiovascular events, has become a public health problem in Mexico. One of its components is atherogenic dyslipidemia, which is made up of hypoalphalipoproteinemia-hypertriglyceridemia and C-LDL on variable, and even normal, levels. However, the international guides indicate C-LDL as the primary objective of the treatment, which means that the goal of correcting TG and C-HDL is frequently omitted in the clinical practice, this maintaining a residual risk in these patients. There is no official recommendation on the treatment of patients with hypertriglyceridemia-hypoalphalipoproteinemia or MS syndrome and C-LDL in the objective or studies on their vascular condition and response to treatment with a fibrate. Objective: To determine the effect of fenofibrate on the lipid profile and the vascular status of patients with described MS and dyslipidemia. Method: A total of 12 patients were included in a prospective, longitudinal, crossed, double blind, placebo controlled study based on fenofibrate 160 mg daily for 8 weeks. The serum lipid profile, endothelium-dependent flow-mediated vasodilatation function and carotid intima-media thickness as control and at the end of the treatment were (..) (AU)

Estimacion de la tasa de transporte de sedimientos para la cuenca de Misicuni / sss

En la presente investigacion se trabajo en la Cuenca Misicuni. Una de las cuencas mas importantes del Proyecto Multiple Misicuni que tiene como objetivo el aprovechamiento de los recursos hidricos de las cuencas Misicuni, Vizcachas y Putucuni, con el fin de asegurar el abastacimiento de agua potable a la ciudad de Cochabamba, proveer de agua para riego al Valle Central de Cochabamba y generar energia hidroelectrica. Para cumplir con dicho objetivo es necesario la construccion de una presa de gran altura para poder embalzar las aguas durante la epoca lluviosa. Una de las variables de importancia para una obra civil de esta embergadura son los sedimientos, de los cuales se tienen poca informacion, para subsanar esta falencia se implemento la apliccion del modelo distribuido AGNPS y determinar la cantidad de sedimientos producidos por la cuenca de Misicuni...

Enfermedad de kawasaki: aspecto de laboratorio / Kawasaki's disease: laboratory aspects

Las alteraciones de laboratorio en la enfermedad de Kawasaki son generalmente no específicas, o aparecen tarde para ser diagnósticas. Es también imperativo establecer evidencia negativa de otras causas conocidas de enfermedad febril aguda, basado en la historia clínica, hallazgos al examen físicoincluyendo hematología, conteo de plaquetas velocidad de eritrosedimentación proteína C-reactiva, título de ASO, examen de orina y tinción de Gram; otra pruebaspueden ser utiles en casos mencionados

Aneurisma coronarios en la enfermedad de kawasaki / Coronary aneurism in kawasaki's disease

Se procede al análisis de la literatura médica en relación al impacto que representa en la emfermedad de Kawasaki, la presencia y trascendencia de los aneurismas coronarios, especialmente entre la población pedríaticaAspectos como diagnóstico, grupo de edad en riesgo, factores de riesgo, pronóstico, aspectos anatomopatológicos son sucesivamente revisados

Enfermedad de Kawasaki: Pautas Terapéuticas. Revisión Bibliográfica / Kawasaki disease: therapeutic guidelines bibliographic review

Se revisa la bibliografía internacional sobre la base de la terapeútica óptima para aquellos niños afectados por la enfermedad de Kawasaki

Estudio diagnóstico en la enfermedad de Kawasaki / Diagnostic studies in Kawasaki's disease

Se destacan por su transcendencia diagnóstica en el Síndrome Linfomucocutaneo (Kawasaki) aquellos procedimientos paraclínicos y técnicas auxiliares que permiten orientar o confirmar la enfermedad. Se parte desde las acostumbradas series radiográficas de rutina, así como los hallazgos típicos electrocardiográficos, para finalmente revisar sucesivamente por la ecocardiografía-bidimensional-Doppler, la arteriografía (coronariografía), pruebas con radioisótopos (Indium 111, Thallium-201), además de la tomografía cardíaca computarizada y la resonancia magnética